Acadia Healthcare Company, Inc.

NASDAQ•ACHC

CEO: Mr. Christopher Howal Hunter

Sector: Healthcare

Industry: Medical - Care Facilities

Listing Date: 1994-03-04

Acadia Healthcare Company, Inc. provides behavioral healthcare services in the United States and Puerto Rico. The company develops and operates acute inpatient psychiatric facilities, specialty treatment facilities comprising residential recovery facilities and eating disorder facilities, comprehensive treatment centers, and residential treatment centers, as well as facilities offering outpatient behavioral healthcare services for the behavioral healthcare and recovery needs of communities. Acadia Healthcare Company, Inc. was founded in 2005 and is headquartered in Franklin, Tennessee.

Contact Information

6100 Tower Circle, Suite 1000, Franklin, TN, 37067, United States

615-861-6000

www.acadiahealthcare.com

Market Cap

$2.33B

P/E (TTM)

-2.1

31.1

Dividend Yield

52W High

$30.20

52W Low

$11.43

52W Range

74%

Rank46Top 59.5%

3.5

F-Score

Modified Piotroski Analysis

Based on 10-year fundamentals

Weak • 3.5 / 9 points

Scoring Range (0-9)

8-9: Excellent Value

6-7: Strong Fundamentals

4-5: Average Quality

0-3: Weak Performance

Data Period: 2016-2025

Financial Dashboard

Q1 2026 Data

Revenue

$828.80M+0.00%

4-Quarter Trend

EPS

$0.05+0.00%

4-Quarter Trend

FCF

-$15.03M+0.00%

4-Quarter Trend

2025 Annual Earnings Highlights

Key Highlights

Revenue Growth Strong Revenue grew 5.0% to $3.31B USD in 2025; same facility revenue increased 4.9% driven by bed additions.

New Credit Facility Secured Secured $1.65B Credit Facility in February 2025, refinancing prior debt; Total Debt stands at $2.50B USD.

Facility Capacity Expansion Operated 277 behavioral facilities with 12,560 beds as of year-end 2025; added 1,089 beds during 2025.

Leverage Ratio Maintained Consolidated Total Net Leverage Ratio was 4.0x at year-end 2025, remaining in compliance with all financial covenants.

Risk Factors

Major Goodwill Impairment Recorded $1.01B USD non-cash goodwill impairment charge in 2025 following triggering event analysis and lower projections.

High Labor Cost Pressure Salaries, wages, and benefits expense was $1.82B USD (55.0% of revenue); turnover increases labor costs impacting profitability.

Large Legal Settlement Costs Incurred $151.0M USD legal settlements expense in 2025, including $147.5M for 2019 Securities Litigation resolution.

Reimbursement Rate Volatility Revenue heavily reliant on Medicaid (57.7%); OBBBA legislation tightens eligibility and reduces federal expenditures.

Outlook

Organic Growth Strategy Focus Strategy emphasizes facility expansions, joint ventures, and de novo builds to expand continuum of care access points.

Managing Capital Structure Actively managing capital structure; ability to fund growth depends on future financing availability on acceptable terms.

Cybersecurity Risk Mitigation Continually enhancing cybersecurity defenses against evolving threats; risks cannot be entirely eliminated per management.

Talent Acquisition Priority Success depends on attracting and retaining qualified psychiatrists, nurses, and support personnel despite intense market competition.

Peer Comparison

Revenue (TTM)

BHC

$10.54B

+8.3%

ARDT

$6.43B

+6.7%

SEM

$5.52B

+29.2%

Gross Margin (Latest Quarter)

INSP

86.5%

+1.8pp

PINC

71.1%

-1.6pp

BHC

61.2%

-0.2pp

Key Metrics

Symbol	Market Cap	P/E (TTM)	ROE (TTM)	Debt to Assets
BKD	$3.17B	-15.5	40118.6%	93.5%
NHC	$3.07B	24.7	11.7%	2.6%
LFST	$3.03B	130.2	1.6%	9.1%

Long-Term Trends

Last 4 Quarters

Revenue

Net Income

Operating Cash Flow

4Q Revenue CAGR

-1.6%

Flat Growth

4Q Net Income CAGR

-48.5%

Declining Profitability

Cash Flow Stability

75%

Volatile Cash Flow

Deep Research

Next earnings:Aug 4, 2026

EPS:$0.35

Revenue:$845.46M

Financials

Earnings Calls

Reports

News

Income Statement

Balance Sheet

Cash Flow Statement

Ratios

% Chg.

Income Statement	LTM

No Data